Intraductal Tubular Adenoma, Pyloric Type, of the Pancreas: Additional Observations on a New Type of Pancreatic Neoplasm

American Journal of Surgical Pathology

Volumn 28, Issue 2, 2004, Pages 233-238

  Albores Saavedra, Jorge ^a,c   Sheahan, Kieran ^b   O'Riain, Ciaran ^b   Shukla, Deepti ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Immunohistochemistry; Intraductal tubular adenoma; Pancreas; Pyloric type

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MUCIN; PERIODIC ACID; PROTEIN P53;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER CELL; CANCER SURVIVAL; CASE REPORT; CELL PROLIFERATION; CHRONIC PANCREATITIS; COLUMNAR EPITHELIUM; CYTOPLASM; ENDOCRINE CELL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PANCREAS ADENOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PERIODIC ACID SCHIFF STAIN; PROTEIN EXPRESSION; STOMACH OBSTRUCTION; SYMPTOMATOLOGY;

ADENOMA; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642453623     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200402000-00011     Document Type: Article

References (20)

1. Adsay NV, Adair C, Heffess C, et al. Intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol. 1996;20:980-994.
2. Adsay NV, Conlon KS, Zee SY, et al. Intraductal papillary-mucinous, neoplasms of the pancreas: an analysis of in situ and invasive carcinoma in 28 patients. Cancer. 2002;94:62-77.
3. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC-1 and MUC-2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
4. rd ed, fascicle 27. Washington, DC: Armed Forces Institute of Pathology, 2000.
5. Albores-Saavedra J, Vardaman CJ, Vuitch F. Non-neoplastic polypoid lesions and adenomas of the gallbladder. PatholAnnu. 1993;28:145-177.
6. Bakotic BW, Robinson MJ, Sturm PD, et al. Pyloric gland adenoma of the main pancreatic duct. Am J Surg Pathol. 1999;23:227-231.
7. Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol. 2000;95:441-445.
8. Fukushima N, Mukai K, Kanai Y, et al. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: clinicopathologic study of 38 cases. Hum Pathol. 1997;28:1010-1017.
9. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579-586.
10. Hruban RH, Van Mansfeld AD, Offerhaus GJ, et al. K ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol. 1993;143:545-554.
11. Ishihara K, Kurihara M, Goso Y. Peripheral alfa-linked N-acetyl-glucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cell: epitope recognized by a newly characterized monoclonal antibody. Biochem J. 1996;318:409-416.
12. Kato N, Akiyama S, Motoyama T. Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas: pyloric gland adenoma of the pancreas. Virchows Arch. 2002;440:205-208.
13. Kodama T, Mori W. Morphologic lesions of the pancreatic ducts: significance of pyloric gland metaplasia in carcinogenesis of the exocrine and endocrine pancreas. Acta Pathol Jpn. 1983;33:645-660.
14. Loftus EV, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology. 1996;110:1909-1918.
15. Luttges J, Diederichs A, Menke MA, et al. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack immunoreactivity for p53. Cancer. 2000; 88:2495-2504.
16. Partensky C, Berger F, Ponchon T, et al. Pancreatectomy for intraductal papillary mucinous tumor of the pancreas. Gastroenterol Clin Biol. 1996; 20:938-945.
17. Rivera JA, Rall CJ, Graeme-Cook F, et al. Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia. Surgery. 1997; 121:42-49.
18. Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996;110:227-231.
19. Yonezawa S, Sato E. Expression of mucin antigens in human cancer and its relationship with malignant potential. Pathol Int. 1997;47:813-830.
20. Z'graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg. 1997;226:491-500.